Compare PGEN & OBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PGEN | OBK |
|---|---|---|
| Founded | 1998 | 1912 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 2013 | 2018 |
| Metric | PGEN | OBK |
|---|---|---|
| Price | $4.12 | $46.16 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | $8.33 | ★ $46.67 |
| AVG Volume (30 Days) | ★ 2.8M | 184.4K |
| Earning Date | 05-13-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 2.13% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 2.40 |
| Revenue | ★ $230,981,000.00 | N/A |
| Revenue This Year | $1,115.92 | $26.43 |
| Revenue Next Year | $81.04 | $5.79 |
| P/E Ratio | ★ N/A | $19.74 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.23 | $32.13 |
| 52 Week High | $5.47 | $48.12 |
| Indicator | PGEN | OBK |
|---|---|---|
| Relative Strength Index (RSI) | 54.94 | 58.25 |
| Support Level | $3.91 | $34.78 |
| Resistance Level | $4.31 | N/A |
| Average True Range (ATR) | 0.19 | 1.19 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 64.01 | 51.00 |
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
Origin Bancorp Inc is a financial holding company that provides personalized, relationship banking to businesses, municipalities, and personal clients in the communities it serves. The company offers a broad range of financial services and operates more than 56 locations in Dallas/Fort Worth, East Texas, Houston, North Louisiana, Mississippi, South Alabama, and the Florida Panhandle. It also provides insurance agency products and services through its wholly owned insurance agency subsidiary. The company operates in one business segment, community banking, and is mainly engaged in attracting deposits from individuals and businesses and using these deposits and borrowed funds to originate commercial, residential mortgage, construction, and consumer loans.